Australia's most trusted
source of pharma news
Thursday, 18 December 2025
Posted 18 December 2025 AM
The time between TGA approval of a medicine and PBS listing has blown out to an average of 726 days, leaving patients waiting longer than ever before.
For more than four years Amgen's Australian Patient Access Gap Tracker has measured the time between TGA authorisation, when a medicine is deemed clinically safe and effective for use, and PBS listing, when a patient gets subsidised access to that medicine.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.